Enzymatica AB (publ) (STO:ENZY)
1.970
+0.010 (0.51%)
Mar 2, 2026, 4:13 PM CET
Enzymatica AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 33.13 | 75.21 | 8.37 | 50.69 | 31.62 |
Cash & Short-Term Investments | 33.13 | 75.21 | 8.37 | 50.69 | 31.62 |
Cash Growth | -55.95% | 799.02% | -83.49% | 60.31% | 31.65% |
Accounts Receivable | 10 | 12.09 | 11.34 | 14.23 | 16.32 |
Other Receivables | 2.98 | 3.31 | 3.13 | 3.48 | 3.75 |
Receivables | 12.98 | 15.4 | 14.47 | 17.71 | 20.07 |
Inventory | 18.92 | 16.71 | 11.5 | 11.51 | 12.44 |
Prepaid Expenses | - | 4.68 | 4.45 | 4.94 | 0.65 |
Total Current Assets | 65.03 | 112 | 38.78 | 84.85 | 64.78 |
Property, Plant & Equipment | 10.37 | 14.4 | 16.48 | 16.4 | 15.16 |
Goodwill | - | 63.21 | 63.21 | 63.21 | 63.21 |
Other Intangible Assets | 64.18 | 0.66 | 1.12 | 1.62 | 1.99 |
Long-Term Deferred Tax Assets | 2.41 | 2.64 | 2.32 | 2.32 | 2.12 |
Long-Term Deferred Charges | - | 2.33 | 4 | 6.02 | 9.79 |
Total Assets | 141.98 | 195.22 | 125.91 | 174.41 | 157.04 |
Accounts Payable | 8.75 | 9.81 | 7.37 | 6.67 | 7.61 |
Accrued Expenses | - | 5.44 | 9.51 | 17.08 | 19.24 |
Current Portion of Long-Term Debt | - | - | - | - | 0.27 |
Current Portion of Leases | 1.02 | 1.18 | 1.22 | 1.2 | 1.24 |
Other Current Liabilities | 8.03 | 1.4 | 14.34 | 2.06 | 2.58 |
Total Current Liabilities | 17.8 | 17.83 | 32.44 | 27 | 30.94 |
Long-Term Debt | 0.01 | - | 14.85 | 20.88 | - |
Long-Term Leases | - | 1.02 | 2.01 | 0.25 | 1.12 |
Other Long-Term Liabilities | -0 | - | - | - | 0 |
Total Liabilities | 17.81 | 18.86 | 49.3 | 48.12 | 32.07 |
Common Stock | 124.17 | 9.71 | 6.57 | 6.57 | 5.97 |
Additional Paid-In Capital | - | 655.9 | 507.2 | 507.2 | 438.83 |
Retained Earnings | - | -490.55 | -437.37 | -387.64 | -318.99 |
Comprehensive Income & Other | - | 1.31 | 0.21 | 0.17 | -0.85 |
Total Common Equity | 124.17 | 176.37 | 76.61 | 126.29 | 124.97 |
Shareholders' Equity | 124.17 | 176.37 | 76.61 | 126.29 | 124.97 |
Total Liabilities & Equity | 141.98 | 195.22 | 125.91 | 174.41 | 157.04 |
Total Debt | 1.02 | 2.2 | 18.08 | 22.32 | 2.63 |
Net Cash (Debt) | 32.11 | 73.01 | -9.71 | 28.37 | 28.99 |
Net Cash Growth | -56.02% | - | - | -2.11% | 216.26% |
Net Cash Per Share | 0.13 | 0.38 | -0.06 | 0.18 | 0.20 |
Filing Date Shares Outstanding | 242.74 | 242.74 | 164.26 | 164.26 | 149.32 |
Total Common Shares Outstanding | 242.74 | 242.74 | 164.26 | 164.26 | 149.32 |
Working Capital | 47.23 | 94.16 | 6.34 | 57.85 | 33.84 |
Book Value Per Share | 0.51 | 0.73 | 0.47 | 0.77 | 0.84 |
Tangible Book Value | 59.99 | 112.5 | 12.28 | 61.46 | 59.78 |
Tangible Book Value Per Share | 0.25 | 0.46 | 0.07 | 0.37 | 0.40 |
Machinery | - | 26.59 | 24.37 | 23.53 | 18.74 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.